Trial met its dual primary endpoints for (1) statistically significant reduction (p=0.0168) in microglial activation as measured by TSPO PET imaging i...
CHICAGO, November 02, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today report...
VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”)...
Two Leading Labs Confirm RHB-204 MAP-Killing Effect for RedHill's Crohn's Disease Candidate
1 day agoRedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the confirmation of RHB-204...
Independent Audit Validates Data Security Controls Across Xtract One View, SmartGateway, and Xtract One GatewayTORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE)...
Thirty-year finance veteran succeeds Thomas Mika; POET to begin quarterly earnings conference calls with fourth-quarter 2026 resultsTORONTO, Nov. 02, ...
NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security equipment, wireless ...
MONTRÉAL, November 02, 2026--Nouveau Monde Graphite Inc. ("NMG" or the "Company") (NYSE : NMG, TSX : NOU) is pleased to announce that it has been gran...
BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecu...
ATCHISON, Kan., November 02, 2026--MGP Ingredients officially becomes Sempreon (Nasdaq: CASK), uniting its businesses under one name and launching sem...
NEW HAVEN, Conn., November 02, 2026--Yarrow Bioscience, Inc. ("Yarrow" or the "Company") (Nasdaq: YARW), a clinical-stage biotechnology company focuse...
Marriott International, Inc. (Nasdaq: MAR) today reported third quarter 2026 results.
SANTA MONICA, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Macerich Company (NYSE: MAC) declared a quarterly cash dividend ...
SAN JOSE, Calif., November 02, 2026--Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal first quarter ended Se...
$127.3 million in 3Q VYJUVEK global revenue and $1.1 billion since launch VYJUVEK pricing negotiations in Germany and Italy completed KB113 clinical d...
Company to Host Conference Call at 8:30am ETREHOVOT, Israel and HOBOKEN, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA...
VANCOUVER, BC / ACCESS Newswire / November 2, 2026 / (TSXV:KALO)(OTCID:KLGDF)(FSE:9M51) ("Kalo," "Kalo Gold" or the "Company") is pleased to announce ...
Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively ...
VANCOUVER, BC & HOUSTON, TX / ACCESS Newswire / November 2, 2026 / ("IBAT" or the "Company") (TSXV:IBAT)(OTCQB:IBATF), an advanced technology provider...
BEDFORD, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed...
Loading...
